Gastrointestinal Cancer | Specialty

The OncLive Gastrointestinal Cancer condition center page is a comprehensive resource for clinical news and expert insights on various types of gastrointestinal (GI) cancers, including hepatocellular carcinoma, gastric cancer, pancreatic cancer, colorectal cancer, cholangiocarcinoma, esophageal cancer, and more. This page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances, and ongoing research in GI cancers.

Research from the 10th World Congress on Gastrointestinal Cancer: Focus on KRAS

May 24th 2010

This month's issue features highlights from the 10th World Congress on Gastrointestinal Cancer (WCGC), held this past June in Barcelona, Spain. The WCGC is an annual meeting that provides scientific sessions and posters on various malignancies of the gastrointestinal tract.

Colon Cancer Oncogene Identified

May 24th 2010

Scientists at the Dana-Farber Cancer Institute, Boston, Massachusetts, have linked the CDK8 gene to colon cancer, a previously unsuspected association.

Study Links Hepatitis B Exposure to Increased Pancreatic Cancer Risk

May 24th 2010

In what researchers are touting as a first-of-its-kind finding, Houston-based University of Texas M. D. Anderson Cancer Center investigators have discovered a potential connection between exposure to the hepatitis B virus and an increased risk of developing pancreatic cancer.

50th Annual Meeting of the American Society of Hematology

January 27th 2009

Highlights from the 50th Annual Meeting of the American Society of Hematology.

Highlights of 2nd Annual ILCA Conference: Cutting-edge Treatments for Hepatocellular Carcinoma

November 17th 2008

Cutting-edge treatments for hepatocellular carcinoma, including contrast-enhanced ultrasound, combined CRT/TACE, sorafenib, & LCCRT for patients with PVT.

Medical Devices: IOERT for Colorectal Cancer

April 14th 2008

Despite improvements in screening that result in detecting this colorectal cancer in earlier stages, the disease remains the second leading cause of cancer death in men and the third in women.